Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.

“Mini-mental state”

1975 • 82,784 citations

Normative data on a battery of neuropsychological tests in the Han Chinese population

2010 • 20,181 citations

Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review

2013 • 20,010 citations

Older Adults' Reasons for Using Technology while Aging in Place

2015 • 19,091 citations

Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly

2014 • 18,386 citations

High-Speed Scanning in Human Memory

1966 • 3,576 citations

Cerebral Blood Flow in Dementia

1975 • 3,133 citations

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

1997 • 2,394 citations

Observations on the brains of demented old people

1970 • 2,066 citations

Dorsolateral prefrontal lesions and oculomotor delayed-response performance: evidence for mnemonic "scotomas"

1993 • 583 citations

Screening for Alzheimer's Disease by Clock Drawing

1989 • 407 citations

The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenyl

1988 • 208 citations

L-Deprenyl in Alzheimer's Disease

1987 • 180 citations

Modulation of gene expression rather than monoamine oxidase inhibition

1996 • 166 citations

The anatomy of dopamine in monkey and human prefrontal cortex

1992 • 163 citations

Deprenyl reduces the death of motoneurons caused by axotomy

1992 • 149 citations

Effects of a MAO-B Inhibitor in the Treatment of Alzheimer Disease

1991 • 145 citations

Neuropsychological Effects of L-Deprenyl in Alzheimerʼs Type Dementia

1990 • 114 citations

<scp>l</scp>‐Deprenyl Protects Mesencephalic Dopamine Neurons from Glutamate Receptor‐Mediated Toxicity In Vitro

1997 • 97 citations

Platelet MAO‐B activity and the psychopathology of Parkinson's disease, senile dementia and multi‐infarct dementia

1988 • 73 citations

L-deprenyl in Alzheimer's disease

1998 • 58 citations

Antioxidant Mechanism and Protection of Nigral Neurons Against MPP⁺ Toxicity by Deprenyl (Selegiline)

1994 • 57 citations

L‐Deprenyl in the Treatment of Mild Dementia of the Alzheimer Type: Results of a 15–Month Trial

1993 • 51 citations

A double-blind crossover pilot study of l-deprenyl (selegiline) combined with cholinesterase inhibitor in Alzheimer's disease

1993 • 47 citations

Brief Information on an Early Phase-ll-Study with Deprenyl in Demented Patients

1987 • 40 citations

Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons

1994 • 35 citations

Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease

1987 • 33 citations

Selegiline as immunostimulant — a novel mechanism of action?

1998 • 33 citations

Age-related memory decline and longevity under treatment with selegiline

1994 • 28 citations

Protection of the aged substantia nigra of the rat against oxidative damage by (−)−deprenyl

1996 • 27 citations

SELEGILINE IN THE TREATMENT OF BEHAVIOURAL DISTURBANCE IN ALZHEIMER'S DISEASE

1997 • 26 citations